GenoLogics

The acquisition will give GenoLogics access to a broad pool of customers and opportunities, and enable deeper integration with Illumina's sequencers and other products.

Illumina has not yet disclosed the price it paid for the Canadian laboratory information management systems software developer.

Under the terms of the purchase, GenoLogics will become part of Illumina's enterprise informatics business.

The company has opened a new office and is hiring to fill multiple positions in software development, support, and more.

GenomeDx has implemented the software at its San Diego laboratory to track information related to the Decipher prostate test. 

NEW YORK (GenomeWeb) – GenoLogics said today that Illumina has selected its Clarity laboratory information management system (LIMS) as the preferred software for customers of its HiSeq X Ten sequencing platform.

GenoLogics has released Clarity LIMS 3.1. It’s the latest version of the company's laboratory information management system for clinical laboratories.

GenoLogics said this week that the Science for Life Laboratory (SciLifeLab), a molecular biosciences research center based in Sweden, will use its Clarity Laboratory Information Management System software to support its next-generation sequencing workflows.

GenoLogics said this week that the upcoming release of its Clarity Laboratory Information Management System will support next generation sequencing workflows and integrations for Illumina's HiSeqX Ten sequencer.

GenoLogics' upcoming release of Clarity LIMS will include functionality to support workflows on the Illumina HiSeq X Ten.

Pages

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.